[Summary] Financial Results for the Six Months Ended September 30, 2026
Filed with TSE · · 2 pages · English
Zeria Pharmaceutical Co., Ltd. on 6ix
Story so far
Earlier from Zeria Pharmaceutical
- Notice Concerning Acquisition of Equity Interests of Haupt Pharma Wulfling GmbH (Making It a Sub-subsidiary) by a Consolidated Subsidiary
- [Updated]Consolidated Financial Results for the First Three Months of the Fiscal Year Ending March 31, 2027[Under Japanese GAAP]
- [Summary] Financial Results for the First Three Months of the Fiscal Year Ending March 31,2027
- 70th Business Report (From April 1, 2023 to March 31, 2024.)
- 69th Business Report (From April 1, 2022 to March 31, 2023.)
Follow Zeria Pharmaceutical into a list and get an email when it puts out news.
Follow Zeria Pharmaceutical